
Medical equipment maker Thermo Fisher's shares TMO.N rise 2.2% to $444.39 premarket
TMO posts Q1 adj. profit of $5.15 per share, beating analysts' estimates of $5.10 per share, according to data compiled by LSEG
Company reports Q1 revenue of $10.36 billion vs estimates of $10.23 billion
Sales at the company's laboratory products segment, which makes up more than half of its total sales, came in at $5.64 billion vs estimate of $5.65 billion
As of last close, TMO has fallen 16.4% YTD